Daniel Morgensztern

2025

Toripalimab for Extensive-Stage Small Cell Lung Cancer

Cali Daylan, A. E., Morgensztern, D. & Waqar, S. N., Jan 16 2025, In: JAMA oncology. 11, 1, p. 26-27 2 p.

Research output: Contribution to journal › Comment/debate

2024

Actionable Structural Variant Detection via RNA-NGS and DNA-NGS in Patients with Advanced Non-Small Cell Lung Cancer

Owen, D., Ben-Shachar, R., Feliciano, J., Gai, L., Beauchamp, K. A., Rivers, Z., Hockenberry, A. J., Harrison, G., Guittar, J., Catela, C., Parsons, J., Cohen, E., Sasser, K., Nimeiri, H., Guinney, J., Patel, J. & Morgensztern, D., Nov 4 2024, In: JAMA Network Open. 7, 11, p. e2442970

Research output: Contribution to journal › Article › peer-review

Open Access

4 Scopus citations

A Phase I First-in-Human Study of ABBV-011, a Seizure-Related Homolog Protein 6-Targeting Antibody-Drug Conjugate, in Patients with Small Cell Lung Cancer

Morgensztern, D., Ready, N., Johnson, M. L., Dowlati, A., Choudhury, N., Carbone, D. P., Schaefer, E., Arnold, S. M., Puri, S., Piotrowska, Z., Hegde, A., Chiang, A. C., Iams, W., Tolcher, A., Nosaki, K., Kozuki, T., Li, T., Santana-Davila, R., Akamatsu, H. & Murakami, H. & 8 others, Yokouchi, H., Wang, S., Zha, J., Li, R., Robinson, R. R., Hingorani, P., Jeng, E. E. & Furqan, M., Nov 15 2024, In: Clinical Cancer Research. 30, 22, p. 5042-5052 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer

Auberle, C., Gao, F., Sloan, M., Morgensztern, D., Winkler, L., Ward, J. P., Devarakonda, S., Rearden, T. P., Govindan, R. & Waqar, S. N., Jun 30 2024, In: Journal of Thoracic Disease. 16, 6, p. 3782-3793 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

A plain language summary of the PHAROS study: the combination of encorafenib and binimetinib for people with BRAF V600E-mutant metastatic non-small-cell lung cancer

Riely, G. J., Smit, E. F., Ahn, M. J., Felip, E., Ramalingam, S. S., Tsao, A., Johnson, M., Gelsomino, F., Esper, R., Nadal, E., Offin, M., Provencio, M., Clarke, J., Hussein, M., Otterson, G. A., Dagogo-Jack, I., Goldman, J. W., Morgensztern, D., Alcasid, A. & Usari, T. & 5 others, Wissel, P., Wilner, K., Pathan, N., Tonkovyd, S. & Johnson, B. E., 2024, In: Future Oncology. 20, 16, p. 1047-1055 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial

Besse, B., Pons-Tostivint, E., Park, K., Hartl, S., Forde, P. M., Hochmair, M. J., Awad, M. M., Thomas, M., Goss, G., Wheatley-Price, P., Shepherd, F. A., Florescu, M., Cheema, P., Chu, Q. S. C., Kim, S. W., Morgensztern, D., Johnson, M. L., Cousin, S., Kim, D. W. & Moskovitz, M. T. & 18 others, Vicente, D., Aronson, B., Hobson, R., Ambrose, H. J., Khosla, S., Reddy, A., Russell, D. L., Keddar, M. R., Conway, J. P., Barrett, J. C., Dean, E., Kumar, R., Dressman, M., Jewsbury, P. J., Iyer, S., Barry, S. T., Cosaert, J. & Heymach, J. V., Mar 2024, In: Nature medicine. 30, 3, p. 716-729 14 p.

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Factors associated with incomplete resection for large, locally invasive non-small cell lung cancer

Brandt, W. S., Yang, Z., Heiden, B. T., Samson, P. P., Morgensztern, D., Waqar, S. N., Meyers, B. F., Nava, R. G., Patterson, G. A., Kozower, B. D. & Puri, V., May 31 2024, In: Journal of Thoracic Disease. 16, 5, p. 2894-2905 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

Incidence and risk factors for bone metastases at presentation in solid tumors

Knapp, B. J., Cittolin-Santos, G. F., Flanagan, M. E., Grandhi, N., Gao, F., Samson, P. P., Govindan, R. & Morgensztern, D., 2024, In: Frontiers in Oncology. 14, 1392667.

Research output: Contribution to journal › Article › peer-review

Open Access

6 Scopus citations

Mesothelioma: Pleural, Version 1.2024 Featured Updates to the NCCN Guidelines

Stevenson, J., Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Desai, A., Dilling, T. J., Dowell, J., Durm, G. A., Garassino, M. C., Gettinger, S., Grotz, T. E., Gubens, M. A. & Lackner, R. P. & 25 others, Lanuti, M., Lin, J., Loo, B. W., Lovly, C. M., Maldonado, F., Massarelli, E., Morgensztern, D., Mullikin, T. C., Ng, T., Otterson, G. A., Owen, D., Patel, S. P., Patil, T., Polanco, P. M., Riely, G. J., Riess, J., Shapiro, T. A., Singh, A. P., Tam, A., Tanvetyanon, T., Yanagawa, J., Yang, S. C., Yau, E., Gregory, K. & Hang, L., Mar 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 2, p. 72-81 10 p.

Research output: Contribution to journal › Article › peer-review

Open Access

12 Scopus citations

Non–Small Cell Lung Cancer, Version 4.2024

Riely, G. J., Wood, D. E., Ettinger, D. S., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Desai, A. P., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Juloori, A. & Lackner, R. P. & 25 others, Lanuti, M., Lin, J., Loo, B. W., Lovly, C. M., Maldonado, F., Massarelli, E., Morgensztern, D., Mullikin, T. C., Ng, T., Owen, D., Owen, D. H., Patel, S. P., Patil, T., Polanco, P. M., Riess, J., Shapiro, T. A., Singh, A. P., Stevenson, J., Tam, A., Tanvetyanon, T., Yanagawa, J., Yang, S. C., Yau, E., Gregory, K. M. & Hang, L., May 2024, In: JNCCN Journal of the National Comprehensive Cancer Network. 22, 4, p. 249-274 26 p.

Research output: Contribution to journal › Article › peer-review

209 Scopus citations

Open-label, dose-escalation FIGHT-101 study of pemigatinib combined with targeted therapy, chemotherapy, or immunotherapy in patients with advanced malignancies

Saleh, M., Barve, M., Subbiah, V., Papadopoulos, K. P., Morgensztern, D., Mettu, N. B., Roychowdhury, S., Spanggaard, I., Veronese, M. L., Tian, C., Silverman, I. M. & Gutierrez, M., Jul 2024, In: ESMO Open. 9, 7, 103625.

Research output: Contribution to journal › Article › peer-review

Open Access

2 Scopus citations

The changing landscape of small cell lung cancer

Cittolin-Santos, G. F., Knapp, B., Ganesh, B., Gao, F., Waqar, S., Stinchcombe, T. E., Govindan, R. & Morgensztern, D., Jul 15 2024, In: Cancer. 130, 14, p. 2453-2461 9 p.

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

The expanding role of circulating tumor DNA in resectable non–small cell lung cancer

Morgensztern, D., May 15 2024, In: Cancer. 130, 10, p. 1730-1732 3 p.

Research output: Contribution to journal › Editorial

1 Scopus citations

2023

Genomic Alterations in Lung Cancer

Morgensztern, D., 2023, Medical Radiology. Springer Science and Business Media Deutschland GmbH, p. 3-16 14 p. (Medical Radiology; vol. Part F1269).

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Mesothelioma: Peritoneal, Version 2.2023

Ettinger, D. S., Wood, D. E., Stevenson, J., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Hegde, A., Lackner, R. P. & Lanuti, M. & 23 others, Lin, J., Loo, B. W., Lovly, C. M., Maldonado, F., Massarelli, E., Morgensztern, D., Mullikin, T. C., Ng, T., Otterson, G. A., Patel, S. P., Patil, T., Polanco, P. M., Riely, G. J., Riess, J., Shapiro, T. A., Singh, A. P., Tam, A., Tanvetyanon, T., Yanagawa, J., Yang, S. C., Yau, E., Gregory, K. M. & Hughes, M., Sep 2023, In: JNCCN Journal of the National Comprehensive Cancer Network. 21, 9, p. 961-979 19 p.

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 2.2023

Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., DeCamp, M., Dilling, T. J., Dowell, J., Durm, G. A., Gettinger, S., Grotz, T. E., Gubens, M. A., Hegde, A., Lackner, R. P., Lanuti, M. & Lin, J. & 23 others, Loo, B. W., Lovly, C. M., Maldonado, F., Massarelli, E., Morgensztern, D., Ng, T., Otterson, G. A., Patel, S. P., Patil, T., Polanco, P. M., Riely, G. J., Riess, J., Schild, S. E., Shapiro, T. A., Singh, A. P., Stevenson, J., Tam, A., Tanvetyanon, T., Yanagawa, J., Yang, S. C., Yau, E., Gregory, K. M. & Hughes, M., Apr 1 2023, In: Journal of the National Comprehensive Cancer Network : JNCCN. 21, 4, p. 340-350 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

292 Scopus citations

Phase Ib Study of Telisotuzumab Vedotin in Combination With Erlotinib in Patients With c-Met Protein-Expressing Non-Small-Cell Lung Cancer

Camidge, D. R., Barlesi, F., Goldman, J. W., Morgensztern, D., Heist, R., Vokes, E., Spira, A., Angevin, E., Su, W. C., Hong, D. S., Strickler, J. H., Motwani, M., Dunbar, M., Parikh, A., Noon, E., Blot, V., Wu, J. & Kelly, K., Feb 10 2023, In: Journal of Clinical Oncology. 41, 5, p. 1105-1115 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

76 Scopus citations

Phase II, Open-Label Study of Encorafenib Plus Binimetinib in Patients with BRAF ^V600-Mutant Metastatic Non-Small-Cell Lung Cancer

Riely, G. J., Smit, E. F., Ahn, M. J., Felip, E., Ramalingam, S. S., Tsao, A., Johnson, M., Gelsomino, F., Esper, R., Nadal, E., Offin, M., Provencio, M., Clarke, J., Hussain, M., Otterson, G. A., Dagogo-Jack, I., Goldman, J. W., Morgensztern, D., Alcasid, A. & Usari, T. & 5 others, Wissel, P., Wilner, K., Pathan, N., Tonkovyd, S. & Johnson, B. E., Jul 20 2023, In: Journal of Clinical Oncology. 41, 21, p. 3700-3711 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

69 Scopus citations

Trends in Stage I Lung Cancer

Singareddy, A., Flanagan, M. E., Samson, P. P., Waqar, S. N., Devarakonda, S., Ward, J., Herzog, B. H., Rohatgi, A., Robinson, C., Gao, F., Govindan, R., Puri, V. & Morgensztern, D., Mar 2023, In: Clinical Lung Cancer. 24, 2, p. 114-119 6 p.

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

2022

A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC

Camidge, D. R., Barlesi, F., Goldman, J. W., Morgensztern, D., Heist, R., Vokes, E., Angevin, E., Hong, D. S., Rybkin, I. I., Barve, M., Bauer, T. M., Delmonte, A., Dunbar, M., Motwani, M., Parikh, A., Noon, E., Wu, J., Blot, V. & Kelly, K., Jan 2022, In: JTO Clinical and Research Reports. 3, 1, 100262.

Research output: Contribution to journal › Article › peer-review

Open Access

21 Scopus citations

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer

Knapp, B., Mezquita, L., Devarakonda, S., Aldea, M., Waqar, S. N., Pepin, K., Ward, J. P., Botticella, A., Howarth, K., Knape, C., Morris, C., Govindan, R., Besse, B. & Morgensztern, D., Mar 28 2022, In: Frontiers in Oncology. 12, 856132.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers

Felip, E., Moreno, V., Morgensztern, D., Curigliano, G., Rutkowski, P., Trigo, J. M., Calvo, A., Kowalski, D., Cortinovis, D., Plummer, R., Maio, M., Ascierto, P. A., Vladimirov, V. I., Cervantes, A., Zudaire, E., Hazra, A., T’jollyn, H., Bandyopadhyay, N., Greger, J. G. & Attiyeh, E. & 2 others, Xie, H. & Calvo, E., Apr 2022, In: Cancer Chemotherapy and Pharmacology. 89, 4, p. 499-514 16 p.

Research output: Contribution to journal › Article › peer-review

Open Access

10 Scopus citations

Non-Small Cell Lung Cancer, Version 3.2022

Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., D'Amico, T. A., DeCamp, M., Dilling, T. J., Dowell, J., Gettinger, S., Grotz, T. E., Gubens, M. A., Hegde, A., Lackner, R. P., Lanuti, M. & Lin, J. & 22 others, Loo, B. W., Lovly, C. M., Maldonado, F., Massarelli, E., Morgensztern, D., Ng, T., Otterson, G. A., Pacheco, J. M., Patel, S. P., Riely, G. J., Riess, J., Schild, S. E., Shapiro, T. A., Singh, A. P., Stevenson, J., Tam, A., Tanvetyanon, T., Yanagawa, J., Yang, S. C., Yau, E., Gregory, K. & Hughes, M., May 2022, In: JNCCN Journal of the National Comprehensive Cancer Network. 20, 5, p. 497-530 34 p.

Research output: Contribution to journal › Article › peer-review

1014 Scopus citations

Phase 1b trial of anti-VEGF/PDGFR vorolanib combined with immune checkpoint inhibitors in patients with advanced solid tumors

Bagegni, N. A., Park, H., Kraft, K., O-Toole, M., Gao, F., Waqar, S. N., Ratner, L., Morgensztern, D., Devarakonda, S., Amin, M., Baggstrom, M. Q., Liang, C., Selvaggi, G. & Wang-Gillam, A., Apr 2022, In: Cancer Chemotherapy and Pharmacology. 89, 4, p. 487-497 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

7 Scopus citations

Phase I Study of Accelerated Hypofractionated Proton Therapy and Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer

Contreras, J., Srivastava, A., Samson, P., DeWees, T., Govindan, R., Baggstrom, M. Q., Morgensztern, D., Roach, M., Badiyan, S. N., Bradley, J., Waqar, S. & Robinson, C., Jul 15 2022, In: International Journal of Radiation Oncology Biology Physics. 113, 4, p. 742-748 7 p.

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Phase i trial of the DLL3/CD3 bispecific T-cell engager BI 764532 in DLL3-positive small-cell lung cancer and neuroendocrine carcinomas

Wermke, M., Felip, E., Gambardella, V., Kuboki, Y., Morgensztern, D., Hamed, Z. O., Liu, M., Studeny, M. & Owonikoko, T. K., Aug 2022, In: Future Oncology. 18, 24, p. 2639-2649 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

39 Scopus citations

Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors

Herzog, B. H., Waqar, S. N., Devarakonda, S., Ward, J. P., Gao, F., Govindan, R. & Morgensztern, D., Nov 2022, In: Lung Cancer. 173, p. 101-106 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

9 Scopus citations

Rationale and Design of the Phase III KEYLYNK-012 Study of Pembrolizumab and Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Stage III Non-Small-Cell Lung Cancer

Jabbour, S. K., Cho, B. C., Bria, E., Kato, T., Bhosle, J., Gainor, J. F., Reguart, N., Wang, L., Morgensztern, D., Shentu, Y., Kim, S. J., Souza, F. & Reck, M., Sep 2022, In: Clinical Lung Cancer. 23, 6, p. e342-e346

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma

Govindan, R., Aggarwal, C., Antonia, S. J., Davies, M., Dubinett, S. M., Ferris, A., Forde, P. M., Garon, E. B., Goldberg, S. B., Hassan, R., Hellmann, M. D., Hirsch, F. R., Johnson, M. L., Malik, S., Morgensztern, D., Neal, J. W., Patel, J. D., Rimm, D. L., Sagorsky, S. & Schwartz, L. H. & 2 others, Sepesi, B. & Herbst, R. S., May 31 2022, In: Journal for ImmunoTherapy of Cancer. 10, 5, e003956.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

2021

A Phase 1–2 Study of Rovalpituzumab Tesirine in Combination With Nivolumab Plus or Minus Ipilimumab in Patients With Previously Treated Extensive-Stage SCLC

Malhotra, J., Nikolinakos, P., Leal, T., Lehman, J., Morgensztern, D., Patel, J. D., Wrangle, J. M., Curigliano, G., Greillier, L., Johnson, M. L., Ready, N., Robinet, G., Lally, S., Maag, D., Valenzuela, R., Blot, V. & Besse, B., Sep 2021, In: Journal of Thoracic Oncology. 16, 9, p. 1559-1569 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

55 Scopus citations

A Phase 1 Study Evaluating Rovalpituzumab Tesirine in Frontline Treatment of Patients With Extensive-Stage SCLC

Hann, C. L., Burns, T. F., Dowlati, A., Morgensztern, D., Ward, P. J., Koch, M. M., Chen, C., Ludwig, C., Patel, M., Nimeiri, H., Komarnitsky, P. & Camidge, D. R., Sep 2021, In: Journal of Thoracic Oncology. 16, 9, p. 1582-1588 7 p.

Research output: Contribution to journal › Article › peer-review

Open Access

34 Scopus citations

A phase II study of everolimus in patients with advanced solid malignancies with TSC1, TSC2, NF1, NF2 or STK11 mutations

Devarakonda, S., Pellini, B., Verghese, L., Park, H., Morgensztern, D., Govindan, R., Suresh, R., Oppelt, P., Baggstrom, M. Q., Wu, N. & Waqar, S. N., Jul 2021, In: Journal of Thoracic Disease. 13, 7, p. 4054-4062 9 p.

Research output: Contribution to journal › Article › peer-review

Open Access

13 Scopus citations

A phase I trial of temsirolimus and erlotinib in patients with refractory solid tumors

Park, H., Williams, K., Trikalinos, N. A., Larson, S., Tan, B., Waqar, S., Suresh, R., Morgensztern, D., Van Tine, B. A., Govindan, R., Luo, J., Lockhart, A. C. & Wang-Gillam, A., Mar 2021, In: Cancer Chemotherapy and Pharmacology. 87, 3, p. 337-347 11 p.

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Durvalumab Consolidation Should Be the Standard Therapy in Stage III EGFR-Mutant NSCLC After Chemoradiation

Morgensztern, D. & Govindan, R., Dec 2021, In: Journal of Thoracic Oncology. 16, 12, p. 1999-2001 3 p.

Research output: Contribution to journal › Editorial

Open Access

5 Scopus citations

Genomic Profiling of Lung Adenocarcinoma in Never-Smokers

Devarakonda, S., Li, Y., Martins Rodrigues, F., Sankararaman, S., Kadara, H., Goparaju, C., Lanc, I., Pepin, K., Waqar, S. N., Morgensztern, D., Ward, J., Masood, A., Fulton, R., Fulton, L., Gillette, M. A., Satpathy, S., Carr, S. A., Wistuba, I., Pass, H. & Wilson, R. K. & 2 others, Ding, L. & Govindan, R., Nov 20 2021, In: Journal of Clinical Oncology. 39, 33, p. 3747-3758 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

66 Scopus citations

Liquid Biopsies: New Technology and Evidence

Morgensztern, D., 2021, Current Cancer Research. Springer Nature, p. 55-64 10 p. (Current Cancer Research).

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis

Langer, C. J., Gajra, A., Gridelli, C., Konduri, K., Morgensztern, D., Spigel, D., Talbot, D., Thomas, M., Weiss, J., Pilot, R., Bhore, R., Wolfsteiner, M., Ong, T. J. & Socinski, M., Jan 26 2021, In: Frontiers in Oncology. 10, 485587.

Research output: Contribution to journal › Article › peer-review

Open Access

5 Scopus citations

nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+)

ABOUND.2L+ investigators, Feb 11 2021, In: Frontiers in Oncology. 10, 569715.

Research output: Contribution to journal › Article › peer-review

Open Access

3 Scopus citations

Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non–Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial

ABOUND.sqm investigators, Jan 2021, In: Clinical Lung Cancer. 22, 1, p. 6-15.e4

Research output: Contribution to journal › Article › peer-review

Open Access

11 Scopus citations

Nivolumab and Ipilimumab as Maintenance Therapy in Extensive-Disease Small-Cell Lung Cancer: CheckMate 451

Owonikoko, T. K., Park, K., Govindan, R., Ready, N., Reck, M., Peters, S., Dakhil, S. R., Navarro, A., Rodríguez-Cid, J., Schenker, M., Lee, J. S., Gutierrez, V., Percent, I., Morgensztern, D., Barrios, C. H., Greillier, L., Baka, S., Patel, M., Lin, W. H. & Selvaggi, G. & 5 others, Baudelet, C., Baden, J., Pandya, D., Doshi, P. & Kim, H. R., Apr 20 2021, In: Journal of Clinical Oncology. 39, 12, p. 1349-1359 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

209 Scopus citations

Non-small cell lung cancer, Version 2.2021 featured updates to the NCCN guidelines

Ettinger, D. S., Wood, D. E., Aisner, D. L., Akerley, W., Bauman, J. R., Bharat, A., Bruno, D. S., Chang, J. Y., Chirieac, L. R., D'Amico, T. A., Dilling, T. J., Dowell, J., Gettinger, S., Gubens, M. A., Hegde, A., Hennon, M., Lackner, R. P., Lanuti, M., Leal, T. A. & Lin, J. & 18 others, Loo, B. W., Lovly, C. M., Martins, R. G., Massarelli, E., Morgensztern, D., Ng, T., Otterson, G. A., Patel, S. P., Riely, G. J., Schild, S. E., Shapiro, T. A., Singh, A. P., Stevenson, J., Tam, A., Yanagawa, J., Yang, S. C., Gregory, K. M. & Hughes, M., Mar 2021, In: JNCCN Journal of the National Comprehensive Cancer Network. 19, 3, p. 254-266 13 p.

Research output: Contribution to journal › Review article › peer-review

Open Access

788 Scopus citations

Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignancies

Lim, K. H., Opyrchal, M., Acharya, A., Boice, N., Wu, N., Gao, F., Webster, J., Lockhart, A. C., Waqar, S. N., Govindan, R., Morgensztern, D., Picus, J., Tan, B. R., Baggstrom, M. Q., Maher, C. A. & Wang-Gillam, A., Sep 2021, In: European Journal of Cancer. 154, p. 102-110 9 p.

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Phase I study of 2- or 3-week dosing of telisotuzumab vedotin, an antibody-drug conjugate targeting c-met, monotherapy in patients with advanced non-small cell lung carcinoma

Camidge, D. R., Morgensztern, D., Heist, R. S., Barve, M., Vokes, E., Goldman, J. W., Hong, D. S., Bauer, T. M., Strickler, J. H., Angevin, E., Motwani, M., Parikh, A., Sun, Z., Bach, B. A., Wu, J., Komarnitsky, P. B. & Kelly, K., Nov 15 2021, In: Clinical Cancer Research. 27, 21, p. 5781-5792 12 p.

Research output: Contribution to journal › Article › peer-review

Open Access

51 Scopus citations

2020

A phase Ib study of GSK3052230, an FGF ligand trap in combination with pemetrexed and cisplatin in patients with malignant pleural mesothelioma

van Brummelen, E. M. J., Levchenko, E., Dómine, M., Fennell, D. A., Kindler, H. L., Viteri, S., Gadgeel, S., López, P. G., Kostorov, V., Morgensztern, D., Orlov, S., Zauderer, M. G., Vansteenkiste, J. F., Baker-Neblett, K., Vasquez, J., Wang, X., Bellovin, D. I., Schellens, J. H. M., Yan, L. & Mitrica, I. & 2 others, DeYoung, M. P. & Trigo, J., Apr 1 2020, In: Investigational New Drugs. 38, 2, p. 457-467 11 p.

Research output: Contribution to journal › Article › peer-review

Open Access

22 Scopus citations

Effect of metastatic site on survival in patients with neuroendocrine neoplasms (NENs). An analysis of SEER data from 2010 to 2014

Trikalinos, N. A., Tan, B. R., Amin, M., Liu, J., Govindan, R. & Morgensztern, D., Apr 3 2020, In: BMC Endocrine Disorders. 20, 1, 44.

Research output: Contribution to journal › Review article › peer-review

Open Access

20 Scopus citations

Mastering the Complex Targeted Therapy for Non-small Cell Lung Cancer

Devarakonda, S., Govindan, R. & Morgensztern, D., Sep 14 2020, In: Cancer Cell. 38, 3, p. 320-322 3 p.

Research output: Contribution to journal › Comment/debate

Open Access

5 Scopus citations

Nab-paclitaxel in older patients with non–small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapy

Weiss, J. M., Pennell, N., Deal, A. M., Morgensztern, D., Bradford, D. S., Crane, J., West, H. J., Lee, C., Pecot, C., Stevenson, J. P., Irvin, W., Socinski, M., Stinchcombe, T., Villaruz, L. C. & Muss, H. B., Mar 1 2020, In: Cancer. 126, 5, p. 1060-1067 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

12 Scopus citations

Phase 2 study of the focal adhesion kinase inhibitor defactinib (VS-6063) in previously treated advanced KRAS mutant non-small cell lung cancer

Gerber, D. E., Camidge, D. R., Morgensztern, D., Cetnar, J., Kelly, R. J., Ramalingam, S. S., Spigel, D. R., Jeong, W., Scaglioni, P. P., Zhang, S., Li, M., Weaver, D. T., Vaikus, L., Keegan, M., Horobin, J. C. & Burns, T. F., Jan 2020, In: Lung Cancer. 139, p. 60-67 8 p.

Research output: Contribution to journal › Article › peer-review

Open Access

109 Scopus citations

Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer

Ponce Aix, S., Talbot, D., Govindan, R., Dols, M. C., Postmus, P. E., Lewanski, C., Bennouna, J., Fischer, J. R., Juan-Vidal, O., Stewart, D. J., Ardizzoni, A., Bhore, R., Wolfsteiner, M., Reck, M., Ong, T. J. & Morgensztern, D., Apr 2020, In: Future Oncology. 16, 12, p. 749-762 14 p.

Research output: Contribution to journal › Article › peer-review

Open Access

SC-002 in patients with relapsed or refractory small cell lung cancer and large cell neuroendocrine carcinoma: Phase 1 study

Morgensztern, D., Johnson, M., Rudin, C. M., Rossi, M., Lazarov, M., Brickman, D. & Fong, A., Jul 2020, In: Lung Cancer. 145, p. 126-131 6 p.

Research output: Contribution to journal › Article › peer-review

Open Access

26 Scopus citations

Daniel Morgensztern

Research output

Search results